An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions

GERD

Interventions

DRUG

Esomeprazole

20mg oral

DRUG

Esomeprazole

15 minute intravenous infusion